Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
OFFschool, under SUL Education, is a free Language Learning Application (LLA) that aims to make English language courses available to everyone who has access to the internet. Students can download the app or register by visiting the OFFschool study website. They need to undertake a placement test to check their language level. The app then prepares daily lessons, assignments and activities that are followed by a weekly progress test. SUL Education asserts that the tests provide a continuous assessment allowing the student to see first-hand the progress they are making. SUL Education is accredited by the Accreditation Body for Language Services (ABLS), UK. SUL Education argues that OFFschool has the potential to reach 600 million 7-19-year-olds. The company will use the investment to invest in its world-class team, create the OFFschool 'Referral Pot', and accelerate its user acquisition efforts through multiple channels.
days to go:
Expired
investment:
£252,130
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.
days to go:
Expired
investment:
£752,246
Ubiqutek is pioneering the use of electricity in the weed control market.
http://ubiqutek.com/
days to go:
Expired
investment:
£133,065
The British Snack Co makes quirky and original British snacks. The company's award-winning flavours and unique ranges of craft popcorn, crisps, and pork snacks have sold over 8 million bags to date. It aims to be a contender in the £3.2 billion UK snacks market. The company's products are stocked across major retailers like Waitrose, Ocado's, Morrisons, Borough Box, and Amazon, to name a few. Its craft pork scratching product, Awfully Posh, was the first pork snack ever to win a Great Taste Award. The company has been working with buyers in the hospitality industry to create joint marketing plans for after lockdown to rapidly grow its Out Of Home (OOH) sales. It will use 50% of the investment to grow its staff, 37.5% towards trade marketing, and 12.5% for New Product Development (NPD).
days to go:
Expired
investment:
£382,495
Fighter Shots (FS) is a company that makes daily energy shots from a range of sources like ginger, turmeric and manuka honey to boost and strengthen human immunity. FS has sold over 50,000 bottles since its launch in November 2019. The functional drinks market has the potential to grow by $180 billion (11% CAGR) to $270 billion from 2020-24 on the back of COVID-19. FS aims to be a disruptor in this segment and asserts that its a dependable substitute to coffee and sugary drinks. It has secured listings with the Health Store, Tree of Life and DDC. The company is also developing sales in the United Arab Emirates (UAE). FS will use the investment to build its digital marketing and sales capabilities to bring its product to more customers.
days to go:
Expired
investment:
£160,000
